iRadimed IRMD Change in Deferred Revenue
Change in Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.
The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about iRadimed's change in deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is iRadimed's change in deferred revenue?
- iRadimed (IRMD) reported change in deferred revenue of $305K in Q1 2026.
- How has iRadimed's change in deferred revenue changed year-over-year?
- iRadimed's change in deferred revenue decreased by 44.2% year-over-year, from $547K to $305K.
- What is the long-term trend for iRadimed's change in deferred revenue?
- Over 2 years (2022 to 2025), iRadimed's change in deferred revenue has grown at a 73.4% compound annual growth rate (CAGR), from $530.58K to $1.6M.
- What does change in deferred revenue mean?
- Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.